People with Chronic Complex Diseases deserve the right to live full, productive lives.
19 World-renowned scientists
2 Nobel Laureates
6 National Academy of Sciences Members
6 OMF established ME / CFS Collaborative Research Centers
at Bateman Horne Center
An initiative to increase access to knowledgeable healthcare providers and improve patient care for those with multi-system Chronic Complex Diseases (msCCD).
OMF's 2022 Year in Review
Thank you for helping us to make this past year one of much progress. In 2023, we will continue to scale our efforts as we pave the way for a brighter future for all those impacted by multi-system chronic, complex diseases (msCCD).
on Charity Navigator!
OMF’s score of 100 serves as an indicator of trust, demonstrating our longstanding commitment to ensuring accountability, transparency, and measures of financial health, including stability, efficiency and sustainability.
OMF ACCELERATES RESEARCH ACROSS THE GLOBE
Since our inception in 2012, Open Medicine Foundation (OMF) has raised over $40 million to fund open and collaborative research and improve health care for millions suffering with multi-system chronic, complex diseases (msCCD). Our disease focus includes Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), Long COVID, Post-Treatment Lyme Disease, and Fibromyalgia.
We have facilitated and funded the establishment of 7 collaborative centers across the globe, in 4 countries and 3 continents. These centers are dedicated to diagnosing, treating, and ultimately curing these related chronic, complex diseases.
Open Medicine Foundation is a US based global nonprofit, with an affiliate organization in Canada (OMF Canada) and a foreign branch in Australia (OMF Australia Ltd). Our 19 member Scientific Advisory Board is world renowned and includes two Nobel laureates and 6 National Academy of Sciences members.
OMF Supported Collaborative Centers
Ronald W. Davis, PhD
Innovative, collaborative, multi-disciplinary research
Wenzhong Xiao, PhD
David Systrom, MD
Clinical and scientific mechanistic studies towards discovering new treatments
at Uppsala, Sweden
Jonas Bergquist, MD, PhD
Research for biomarkers in body and brain
at Bateman Horne Center
Lucinda Bateman, MD
Medical Education Director
A global initiative to increase access to knowledgeable healthcare providers and improve patient care.
Long Covid TO ME/CFS RESEARCH PLAN
The current COVID-19 pandemic offers an unprecedented opportunity to understand how a viral infection may convert to ME/CFS in some patients.
The six Collaborative Research Centers have begun a unique, extensive, in-depth longitudinal molecular study following COVID-19 patients. Their shared goal is to determine the pathways involved in maintaining long-term symptoms in some patients, possibly converting to ME/CFS. They seek to learn about these pathways so as to develop biomarkers, novel drug targets, new treatment, and prevention strategies.
View our latest news
Discover the latest advancements in ME/CFS research with the second installment of the Itaconate Shunt Hypothesis video, with Robert Phair PhD and Janet Dafoe, PhD
My name is John. I was a career firefighter/paramedic who was exposed to a person with COVID at work in December 2020 before vaccines were
Highlights and progress: OMF’s 2022 Year in Review
Join our Fight to Ignite ME / CFS Research
Across the Globe!
OMF’s international community —
United by a shared commitment to find answers to end ME / CFS and related multi-system chronic, complex diseases (msCCD).
The Faces of ME / CFS
What is ME / CFS?
Join OMF to Find A Cure
Take Action Now!
Please help us expand our research efforts across the globe.
Every donation brings us closer to a fully funded research effort and the answers we all seek.